# Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP

> **NCT01623570** · NA · COMPLETED · sponsor: **Centro Riproduzione e Andrologia** · enrollment: 40 (actual)

## Conditions studied

- Hypogonadotropic Hypogonadism

## Interventions

- **DRUG:** Pergoveris: 150IU r-hFSH + 75IU r-hLH
- **DRUG:** Menopur: HMG-HP (150 IU)

## Key facts

- **NCT ID:** NCT01623570
- **Lead sponsor:** Centro Riproduzione e Andrologia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01623570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01623570, "Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01623570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*